Ongoing efforts to reduce perioperative morbidity of radical cystectomy: towards widespread adoption of extended-duration thromboprophylaxis

Radical cystectomy (RC) is the gold standard treatment for muscle invasive and select high-risk non-muscle invasive bladder cancers. The operation is well known to pose significant perioperative morbidity (1). Venous thromboembolic events (VTE) remain a major and increasingly acknowledged complication of RC.